Studies support dexmedetomidine for ICU ventilation patients

03/22/2012 | MedPage Today (free registration)

Dexmedetomidine, a lighter sedative that does not have respiratory depressive effects, was as effective as midazolam or propofol for long-term sedation in ventilated ICU patients, Bern University researchers reported in two studies in the Journal of the American Medical Association. Data also showed dexmedetomidine may reduce the duration of ventilation and that patients were more easily aroused and better able to communicate with staff compared with those on midazolam.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD